Oramed Pharmaceuticals Inc - Understand $ormp stock

$ORMP Market Cap: $101.5 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$0.00

TTM

Gross Margin

Net Earnings

$20.86M

TTM

Current Assets

$153.3M

Q2 2024

Current Liabilities

$3.733M

Q2 2024

Current Ratio

4105.81%

Q2 2024

Total Assets

$184.2M

Q2 2024

Total Liabilities

$8.069M

Q2 2024

Book Value

$176.2M

Q2 2024

Cash

$84.75M

Q2 2024

P/E

4.866

Sep 13, 2024 EST

Free Cash Flow

-$1.553M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Revenue	$1.340M	$2.703M	$904.0K	$2.710M	$2.700M	$2.450M	$2.460M	$640.0K	$0.00	$0.00	$309.2K	$373.0K	$349.7K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-50.43%	199.0%	-66.64%	0.37%	10.2%	-0.41%	284.38%			-100.0%	-17.11%	6.64%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Revenue	$1.340M	$2.703M	$904.0K	$2.710M	$2.700M	$2.450M	$2.460M	$640.0K	$0.00	$0.00	$309.2K	$373.0K	$349.7K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Cost Of Revenue				$0.00	$90.00K	-$90.00K	$190.0K	$490.0K	$490.0K
Gross Profit				$2.710M	$2.610M	$2.540M	$2.270M	$150.0K	$150.0K
Gross Profit Margin				100.0%	96.67%	103.67%	92.28%	23.44%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Selling, General & Admin	$8.425M	$15.66M	$4.193M	$4.230M	$3.720M	$4.080M	$2.760M	$2.450M	$2.600M	$2.630M	$2.030M	$1.200M	$1.280M	$1.510M	$1.210M	$1.470M	$920.0K	$220.0K	$50.00K	$280.0K	$50.00K	$10.00K	$10.00K
YoY Change	-46.21%	273.53%	-0.87%	13.71%	-8.82%	47.83%	12.65%	-5.77%	-1.14%	29.56%	69.17%	-6.25%	-15.23%	24.79%	-17.69%	59.78%	318.18%	340.0%	-82.14%	460.0%	400.0%	0.0%
% of Gross Profit				156.09%	142.53%	160.63%	121.59%	1633.33%	1733.33%
Research & Development	$8.971M	$27.64M	$9.037M	$10.24M	$13.52M	$11.98M	$10.28M	$7.710M	$4.780M	$3.277M	$2.272M	$1.681M	$1.159M	$1.460M	$1.570M	$1.210M	$2.210M	$200.0K	$0.00	$0.00	$10.00K	$0.00	$0.00
YoY Change	-67.54%	205.84%	-11.75%	-24.26%	12.85%	16.54%	33.33%	61.3%	45.87%	44.23%	35.16%	45.0%	-20.6%	-7.01%	29.75%	-45.25%	1005.0%			-100.0%
% of Gross Profit				377.86%	518.01%	471.65%	452.86%	5140.0%	3186.67%
Depreciation & Amortization	$196.0K	$58.00K	$18.00K	$10.00K	$10.00K	$10.00K	$10.00K	$0.00	$0.00	$6.000K	$5.000K	$15.00K	$28.30K	$30.00K	$30.00K	$20.00K	$0.00	$0.00
YoY Change	237.93%	222.22%	80.0%	0.0%	0.0%	0.0%			-100.0%	20.0%	-66.67%	-47.0%	-5.66%	0.0%	50.0%
% of Gross Profit				0.37%	0.38%	0.39%	0.44%	0.0%	0.0%
Operating Expenses	$8.971M	$27.64M	$13.23M	$14.47M	$17.24M	$16.07M	$13.04M	$10.16M	$7.380M	$3.277M	$2.272M	$1.681M	$1.159M	$2.970M	$2.780M	$2.680M	$3.130M	$410.0K	$50.00K	$280.0K	$50.00K	$10.00K	$10.00K
YoY Change	-67.54%	108.91%	-8.57%	-16.07%	7.28%	23.24%	28.35%	37.67%	125.21%	44.23%	35.16%	45.0%	-60.97%	6.83%	3.73%	-14.38%	663.41%	720.0%	-82.14%	460.0%	400.0%	0.0%
Operating Profit	-$15.77M	-$40.60M		-$11.76M	-$14.63M	-$13.53M	-$10.77M	-$10.01M	-$7.230M	-$5.906M	-$4.304M	-$2.884M	-$2.435M
YoY Change	-61.16%			-19.62%	8.13%	25.63%	7.59%	38.45%	22.42%	37.22%	49.24%	18.43%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003
Interest Expense	$2.037M	$3.473M	$71.00K	$260.0K	$630.0K	$900.0K	$790.0K	$470.0K	$170.0K	$138.0K	$19.00K	$13.00K	$1.050M	$10.00K	$20.00K	$70.00K	-$100.0K	$0.00	$0.00	$0.00	$0.00
YoY Change	-41.35%	4791.55%	-72.69%	-58.73%	-30.0%	13.92%	68.09%	176.47%	23.19%	626.32%	46.15%	-98.76%	10400.0%	-50.0%	-71.43%	-170.0%
% of Operating Profit
Other Income/Expense, Net	$22.89M	$264.0K	$124.0K	-$10.00K	-$50.00K	-$100.0K	-$100.0K	-$90.00K	-$20.00K	-$10.00K	$10.00K	$10.00K
YoY Change	8571.97%	112.9%	-1340.0%	-80.0%	-50.0%	0.0%	11.11%	350.0%	100.0%	-200.0%	0.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Pretax Income	$5.088M	$11.16M	-$12.26M	-$11.51M	-$14.06M	-$12.73M	-$10.08M	-$9.630M	-$7.230M	-$5.692M	-$4.437M	-$3.254M	-$1.585M	-$2.960M	-$2.760M	-$2.610M	-$3.240M	-$420.0K	-$50.00K	-$720.0K	-$50.00K	-$10.00K	-$10.00K
YoY Change	-54.42%	-191.1%	6.47%	-18.14%	10.45%	26.29%	4.67%	33.2%	27.02%	28.28%	36.36%	105.27%	-46.45%	7.25%	5.75%	-19.44%	671.43%	740.0%	-93.06%	1340.0%	400.0%	0.0%
Income Tax		$100.0K		$0.00	$300.0K	$0.00	$400.0K	$1.340M	$0.00	$4.000K	-$205.0K	$90.00K	-$23.98K	$10.00K	$0.00	$160.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
% Of Pretax Income		0.9%
Net Earnings	$5.525M	-$37.76M	-$11.67M	-$11.51M	-$14.36M	-$12.73M	-$10.48M	-$10.96M	-$7.230M	-$5.696M	-$4.232M	-$3.344M	-$1.561M	-$2.977M	-$2.760M	-$2.769M	-$3.240M	-$420.0K	-$50.00K	-$720.0K	-$50.00K	-$10.00K	-$10.00K
YoY Change	-114.63%	223.65%	1.37%	-19.85%	12.8%	21.47%	-4.38%	51.59%	26.93%	34.59%	26.56%	114.19%	-47.56%	7.86%	-0.32%	-14.53%	671.43%	740.0%	-93.06%	1340.0%	400.0%	0.0%
Net Earnings / Revenue	412.31%	-1397.11%	-1290.71%	-424.72%	-531.85%	-519.59%	-426.02%	-1712.5%			-1368.89%	-896.61%	-446.42%
Basic Earnings Per Share	$0.14	$0.94
Diluted Earnings Per Share	$0.14	$0.94	-$314.4K	-$560.6K	-$822.9K	-$855.5K	-$787.4K	-$868.5K	-$668.2K	-$616.9K	-$586.7K	-$568.0K	-$287.8K	-$623.4K	-$584.7K	-$684.0K	-$920.5K	-$151.1K	-$32.47K	-$283.5K	-$17.24K	-$7.092K	-$7.092K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Cash & Short-Term Investments	$162.0M	$155.7M	$146.3M	$39.90M	$32.28M	$30.46M	$20.12M	$31.02M	$17.23M	$21.29M	$8.480M	$5.090M	$3.700M	$1.300M	$2.720M	$5.000M	$1.920M	$180.0K	$0.00	$0.00	$0.00	$40.00K	$40.00K
YoY Change	4.06%	6.45%	266.62%	23.61%	5.98%	51.39%	-35.14%	80.03%	-19.07%	151.06%	66.6%	37.57%	184.62%	-52.21%	-45.6%	160.42%	966.67%				-100.0%	0.0%
Cash & Equivalents	$9.055M	$40.46M	$27.46M	$19.30M	$3.330M	$5.000M	$3.970M	$3.910M	$3.210M	$1.760M	$2.270M	$4.430M	$1.510M	$1.200M	$1.720M	$2.270M	$1.920M	$1.920M
Short-Term Investments	$153.0M	$115.3M	$118.8M	$20.60M	$28.95M	$25.47M	$16.15M	$27.11M	$14.02M	$19.53M	$6.200M	$650.0K	$2.190M	$100.0K	$1.000M	$2.730M	$0.00	$0.00
Other Short-Term Assets	$537.0K	$1.389M	$1.657M	$610.0K	$1.040M	$570.0K	$180.0K	$220.0K	$150.0K	$80.00K	$50.00K	$60.00K	$20.00K	$20.00K	$20.00K	$360.0K	$10.00K	$0.00	$0.00	$0.00	$0.00
YoY Change	-61.34%	-16.17%	171.64%	-41.35%	82.46%	216.67%	-18.18%	46.67%	87.5%	60.0%	-16.67%	200.0%	0.0%	0.0%	-94.44%	3500.0%
Inventory
Prepaid Expenses
Receivables													$540.0K	$60.00K	$40.00K	$40.00K	$40.00K
Other Receivables													$30.00K	$20.00K	$400.0K	$0.00	$0.00
Total Short-Term Assets	$162.6M	$157.1M	$147.9M	$40.51M	$33.32M	$31.04M	$20.30M	$31.23M	$17.37M	$21.78M	$8.640M	$5.280M	$4.280M	$1.400M	$3.170M	$5.400M	$1.930M	$180.0K	$0.00	$0.00	$0.00	$40.00K	$40.00K
YoY Change	3.48%	6.2%	265.19%	21.58%	7.35%	52.91%	-35.0%	79.79%	-20.25%	152.08%	63.64%	23.36%	205.71%	-55.84%	-41.3%	179.79%	972.22%				-100.0%	0.0%
Property, Plant & Equipment	$1.567M	$1.802M	$888.0K	$170.0K	$20.00K	$20.00K	$20.00K	$20.00K	$10.00K	$10.00K	$10.00K	$0.00	$20.00K	$40.00K	$80.00K	$100.0K	$0.00	$0.00	$0.00
YoY Change	-13.04%	102.93%	422.35%	750.0%	0.0%	0.0%	0.0%	100.0%	0.0%	0.0%		-100.0%	-50.0%	-50.0%	-20.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$56.37M	$2.707M	$28.97M	$3.930M	$1.300M	$16.33M	$18.38M	$11.57M	$8.960M	$0.00	$0.00	$10.00K	$10.00K	$10.00K	$10.00K	$10.00K	$10.00K	$0.00	$0.00
YoY Change	1982.49%	-90.66%	637.12%	202.31%	-92.04%	-11.15%	58.86%	29.13%			-100.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Other Assets	$27.00K	$24.00K	$26.00K	$20.00K	$20.00K	$20.00K	$10.00K	$10.00K	$10.00K	$10.00K	$10.00K	$0.00	$10.00K	$0.00	$0.00
YoY Change	12.5%	-7.69%	30.0%	0.0%	0.0%	100.0%	0.0%	0.0%	0.0%	0.0%		-100.0%
Total Long-Term Assets	$57.97M	$4.533M	$29.88M	$4.120M	$1.340M	$16.36M	$18.41M	$11.60M	$8.980M	$20.00K	$20.00K	$10.00K	$50.00K	$50.00K	$90.00K	$110.0K	$10.00K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	1178.78%	-84.83%	625.32%	207.46%	-91.81%	-11.14%	58.71%	29.18%	44800.0%	0.0%	100.0%	-80.0%	0.0%	-44.44%	-18.18%	1000.0%
Total Assets	$220.6M	$161.6M	$177.8M	$44.63M	$34.66M	$47.40M	$38.71M	$42.83M	$26.35M	$21.80M	$8.660M	$5.290M	$4.330M	$1.450M	$3.260M	$5.510M	$1.940M	$180.0K	$0.00	$0.00	$0.00	$40.00K	$40.00K
YoY Change
Accounts Payable	$551.0K	$2.175M	$4.535M	$590.0K	$1.340M	$1.140M	$570.0K	$1.410M	$950.0K	$930.0K	$390.0K	$580.0K	$340.0K	$380.0K	$320.0K	$680.0K	$50.00K	$50.00K	$40.00K	$10.00K	$0.00	$0.00	$0.00
YoY Change	-74.67%	-52.04%	668.64%	-55.97%	17.54%	100.0%	-59.57%	48.42%	2.15%	138.46%	-32.76%	70.59%	-10.53%	18.75%	-52.94%	1260.0%	0.0%	25.0%	300.0%
Accrued Expenses	$1.325M	$2.219M	$130.0K	$1.130M	$1.170M	$890.0K	$1.690M	$1.690M			$60.00K	$20.00K	$50.00K	$30.00K	$30.00K	$70.00K	$70.00K
YoY Change	-40.29%	1606.92%	-88.5%	-3.42%	31.46%	-47.34%	0.0%				200.0%	-60.0%	66.67%	0.0%	-57.14%	0.0%
Deferred Revenue
YoY Change
Short-Term Debt	$51.01M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$280.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change																-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$53.21M	$5.746M	$7.368M	$4.540M	$5.310M	$4.550M	$5.170M	$3.620M	$1.490M	$970.0K	$500.0K	$640.0K	$440.0K	$460.0K	$370.0K	$780.0K	$1.420M	$610.0K	$50.00K	$0.00	$10.00K	$0.00	$0.00
YoY Change	826.11%	-22.01%	62.29%	-14.5%	16.7%	-11.99%	42.82%	142.95%	53.61%	94.0%	-21.88%	45.45%	-4.35%	24.32%	-52.56%	-45.07%	132.79%	1120.0%		-100.0%
Long-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$4.444M	$4.740M	$3.842M	$7.220M	$9.960M	$11.73M	$14.31M	$13.02M	$40.00K	$40.00K	$30.00K	$870.0K	$160.0K	$160.0K	$150.0K	$130.0K	$130.0K
YoY Change	-6.24%	23.37%	-46.79%	-27.51%	-15.09%	-18.03%	9.91%	32450.0%	0.0%	33.33%	-96.55%	443.75%	0.0%	6.67%	15.38%	0.0%
Total Long-Term Liabilities	$4.444M	$4.740M	$3.842M	$7.220M	$9.960M	$11.73M	$14.31M	$13.02M	$40.00K	$40.00K	$30.00K	$870.0K	$160.0K	$160.0K	$150.0K	$130.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-6.24%	23.37%	-46.79%	-27.51%	-15.09%	-18.03%	9.91%	32450.0%	0.0%	33.33%	-96.55%	443.75%	0.0%	6.67%	15.38%
Total Liabilities	$56.73M	$9.830M	$11.37M	$11.75M	$15.27M	$16.29M	$19.47M	$16.64M	$1.530M	$1.010M	$530.0K	$1.520M	$600.0K	$620.0K	$520.0K	$910.0K	$1.420M	$610.0K	$50.00K	$0.00	$10.00K	$0.00	$0.00
YoY Change	477.11%	-13.52%	-3.26%	-23.05%	-6.26%	-16.33%	17.01%	987.58%	51.49%	90.57%	-65.13%	153.33%	-3.23%	19.23%	-42.86%	-35.92%	132.79%	1120.0%		-100.0%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022
Basic Shares Outstanding	40.32M shares	39.00M shares
Diluted Shares Outstanding	40.57M shares	39.00M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Dividends

Stock Price

Market Cap: $101.51 Million

About Oramed Pharmaceuticals Inc

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. The company is headquartered in New York City, New York and currently employs 15 full-time employees. The company went IPO on 2002-04-01. The firm has developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its Protein Oral Delivery (POD) technology is designed to protect drug integrity and increase absorption. Its pipeline includes ORMD-0801 (Oral Insulin) Diabetes, ORMD-0801 (Oral Insulin) NASH, and ORMD 0901 (Oral GLP-1). Its oral insulin (ORMD-0801) has the potential to create a new paradigm in the treatment of diabetes through oral delivery of insulin at an earlier stage of treatment. Its oral insulin capsule (ORMD-0801) has shown a reduction of liver fat content in early clinical trials. The company is also developing an oral Glucagon-like peptide-1 (GLP-1) analog capsule (ORMD-0901), which is an incretin hormone that stimulates the secretion of insulin from the pancreas.

Industry: Pharmaceutical Preparations Peers: AN2 Therapeutics Inc Biote Corp CymaBay Therapeutics, Inc. EyePoint Pharmaceuticals Inc Johnson & Johnson Marinus Pharmaceuticals Inc OptiNose Inc